Hi-VNI Technology – Effective and Gentle Ventilatory Support
Vapotherm Hi-VNI Technology offers a viable alternative to mask therapies (CPAP, NIPPV) for adult patients in acute respiratory distress using a simple nasal cannula.
Hi-VNI Technology can be used as a tool to treat the signs and symptoms of acute respiratory distress in adult patients and help reduce the need for more invasive pressure based therapies, including mechanical ventilation. It also can be used as a weaning tool for patients recently liberated from the ventilator to support their continued oxygenation needs and reduce their work of breathing.
Simplify Patient Care
No need to spend time choosing the right mask size and elbow, coaching/calming or sedating patients due to mask intolerance. With Vapotherm, you can focus on patient care.
Patients can speak, eat, drink and take their oral medicine without disruption in therapy, making for a more positive experience for them and their visiting families and friends.
Adult Care Areas
The integrated Vapotherm Hi-VNI system is easy to set up and operate in the Emergency Department environment, and provides acute relief of the signs and symptoms of respiratory distress, such as hypercapnia and hypoxemia.
High flows of oxygenated, heated breathing gas delivered through a small prong cannula reduce work of breathing, while optimal humidification protects and rehydrates irritated respiratory tissue and mobilizes secretions.
Adult Intensive Care
Vapotherm Hi-VNI Technology is an ideal respiratory solution for patients that require care in the Intensive Care Unit. Therapy is delivered through a simple nasal cannula that may increase patient compliance compared to mask – based therapies. With Vapotherm, clinicians can focus on their patients and not the equipment.
Vapotherm Hi-VNI increases efficiency of oxygenation and alveolar ventilation despite the shallow breaths common with surgery patients. It may allow earlier extubation of patients, when every hour of mechanical ventilation increases costs and risk.
General Care Floor
With patient-focused alarms and alerts on a large digital display, clinicians can have confidence that the therapy set is what is delivered to the patient.
Long Term Acute Care
Typically, 30% of Long Term Acute Care Patients are prolonged mechanical ventilator patients that have received a tracheostomy. These patients are transitioned to LTACHs to be weaned from the ventilator and eventually decannulated (removal of their tracheostomy tube). Although individual results may vary, data collected by Vapotherm's LTACH Centers of Excellence suggests that Vapotherm's humidification may help accelerate the weaning and decannulation process.
The Vapotherm Precision Flow can help treat the signs and symptoms of respiratory distress. Respiratory distress manifests as acute difficulty breathing including dyspnea, tachypnea and labored breathing (e.g. as manifested by accessory muscle use). For example, these symptoms might be experienced by a patient with COPD exacerbation.
Vapotherm is a tool commonly used to address the signs and symptoms of patients of respiratory distress secondary to a COPD exacerbation while in the acute care setting. Patients find the therapy very comfortable. Nurses and staff appreciate the high patient tolerance and the ability of patients on mask-free therapy to eat, drink, take their medications and interact with healthcare providers and family.
Vapotherm has been used as a tool to support the signs and symptoms of patients in respiratory distress secondary to CHF to reduce the work of breathing.
Vapotherm Hi-VNI Technology manages dyspnea by delivering high flows of ideally conditioned gas through a nasal cannula. By delivering the gas at body temperature and with humidification, Vapotherm not only prevents increased airway resistance caused by drying and cooling of the airway, but also may offset the amount of work the body needs to expend on naturally heating and humidifying inspired air.
Vapotherm Hi-VNI Technology can be an effective tool for managing the signs and symptoms of respiratory distress secondary to pneumonia. This relieves the signs and symptoms of respiratory distress while antibiotics or other therapies relieve the infection.
Successful application of Hi-VNI may also prevent the need for more invasive therapies such as bi-level non-invasive ventilation and mechanical ventilation.
Prolonged Mechanical Ventilation
With respiratory support being delivery directly through a tracheostomy tube, these patients are bypassing their upper airway which would naturally heat and humidify the air. Providing proper humidification to these patients is an essential part of their recovery.
Comfort at End of Life
Dyspnea (shortness of breath) is one of the most frequent complaints among palliative care and hospice care patients.
A study conducted by MD Anderson in Houston indicates that High Flow Therapy also may effectively improve persistent dyspnea in patients already being treated with current standard of care (i.e. opioids and supplemental oxygen).1
1 J Pain Symptom Manage. 2013 Oct;46(4):463-73. doi: 10.1016/j.jpainsymman.2012.10.284. Epub 2013 Jun 2.
Adult Clinical Applications
Mask – Free, Primary Respiratory Support
Replace the mask for your respiratory distress patients with a comfortable nasal cannula. Vapotherm Hi-VNI delivers heated humidified breathing gas through a small bore nasal cannula. The high velocity flows have been shown to be an effective tool in the management of the signs and symptoms of respiratory distress experienced by patient with COPD and CHF exacerbations, including hypoxemia.
Relieve the Pressure for Post-Extubation Patients
Vapotherm provides effective respiratory support without elevating the acuity of care (mask, pressure-based therapies). A study conducted by the University of Maryland Medical Center showed that 77% of patients that received Vapotherm support post-extubation did not require re-intubation and were successfully weaned off the therapy.
Solutions to Keep Patients Moving
When it’s time to transfer patients out of the Emergency Room or participate in rehabilitation Vapotherm has solutions to keep your patients on Hi-VNI Technology.
Humidification Patients Need
Vapotherm humidification mobilizes secretions to improve airway clearance for trach patients. Although individual results may vary, data collected by Vapotherm's LTACH Centers of Excellence suggests that Vaptherm's humidification may accelerate ventilator weaning and decannulation.
Comfortable Support Patients Need
Many palliative care patients suffer from dyspnea, that is typically treated with low flow, dry oxygen or pressure based therapies. Vapotherm Hi-VNI uses humidified breathing gas with a simple nasal cannula interface to maximize patient comfort.
Patients can eat and speak with their caregivers and loved ones - which can support family contact at this important time.